Abstract
Hydrogen sulfide (H2S), an endogenously generated and regulated signaling gas, plays a vital role in a variety of (patho)physiological processes. In the past few years, different kinds of H2S-releasing compounds (often referred to as H2S donors) have been developed for H2S delivery, but it is still challenging to make H2S donors with tunable payloads in a simple and efficient manner. Herein, a series of peptide-H2S donor conjugates (PHDCs) with tunable donor loadings are designed for controlled H2S release. The PHDCs self-assemble into nanoribbons with different geometries in aqueous solution. Upon addition of cysteine, these nanostructures release H2S, delivering their payload into H9C2 cells, as visualized using an H2S-selective fluorescent probe. Beyond imaging, in vitro studies show that the ability of PHDCs to mitigate doxorubicin-induced cardiotoxicity in H9C2 cardiomyocytes depends on their nanostructures and H2S release profiles. This strategy may enable the development of sophisticated H2S-releasing biomaterials for drug delivery and regenerative medicine.
Accepted Version
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call